Loading chat...

FL S0844

Bill

Official Source

Status

Engrossed

2/25/2026

Primary Sponsor

Appropriations Committee on Health and Human Services

Click for details

Origin

Senate

2026 Regular Session

AI Summary

  • Requires health care practitioners authorized to prescribe controlled substances to complete continuing education that includes training on pain treatment for patients with sickle cell disease
  • Amends existing 2-hour board-approved continuing education course on prescribing controlled substances to add sickle cell disease pain management as a mandatory topic
  • Applies to all prescribers registered with the U.S. Drug Enforcement Administration as part of biennial license renewal requirements
  • Effective date of July 1, 2026

Legislative Description

Sickle Cell Disease Care Management and Treatment Continuing Education

Last Action

CS passed; YEAS 113, NAYS 0

3/11/2026

Committee Referrals

Fiscal Policy2/13/2026
Appropriations Subcommittee on Health and Human Services2/3/2026

Full Bill Text

No bill text available